ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., and PARIS, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med, a clinical-stage radiopharmaceutical company and a pioneer…
RENO, Nev., July 07, 2025 (GLOBE NEWSWIRE) -- Monarch Casino & Resort, Inc. (NASDAQ: MCRI) announced today that it will release its 2025 second quarter financial results after the market closes on Wednesday, July 16, 2025.
Ningde, Fujian, China, July 07, 2025 (GLOBE NEWSWIRE) -- Oriental Rise Holdings Limited (Nasdaq: ORIS) (“Oriental Rise” or the “Company”), an integrated supplier of white- and black-tea products in mainland China, today announced that on June 30, 2025 it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is…
7 July 2025 HARGREAVE HALE AIM VCT PLC (the “Company”) NAV announcement As at close of business on 30 June 2025, the unaudited Net Asset Value (NAV) for Hargreave Hale AIM VCT plc was as follows: NAV per Ordinary share of 1p Cum Dividend – 36.43 pence.
SAN DIEGO, July 07, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP, is investigating whether BellRing Brands, Inc. (NYSE: BRBR), or any of its executive officers, violated securities laws by misrepresenting or failing to timely disclose material information to investors.
MARKHAM, Ontario, July 07, 2025 (GLOBE NEWSWIRE) -- Almost one third (32 per cent) of Canadian respondents to a survey that say they are active on social media post about their plans before or while traveling, a figure that rises to 51 per cent among those aged 18 to 34. Posting that beach vacation selfie…
Sun, 22 Jun 2025 08:00:00 GMT MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano Med Promising tumor ...
Sun, 12 Jan 2025 10:09:00 GMT Molecular Partners and Orano Med expand collaboration to develop ten 212Pb-Radio-DARPin therapy candidates, ... This is an AI-generated summary of a press release distributed by GlobeNewswire.
Sun, 12 Jan 2025 10:03:00 GMT Molecular Partners will lead development of the additional six programs, subject to a royalty arrangement, and include an option for Orano Med to move two of the six programs into a 50/50 ...
Sun, 12 Jan 2025 10:00:00 GMT New agreement enables both companies to fuel a broad and innovative pipeline of 212 Pb-Radio-DARPin candidates, bringing the total number of programs up to ten Expanded partnership highlights the ...
Mon, 21 Oct 2024 23:00:00 GMT Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin ... this press release contains information relating to interim data as of the relevant data ...
